p63 tumour protein IVD, antibody

This category includes in vitro diagnostic (IVD) antibody-based tests designed to detect the presence or measure levels of the p63 tumour protein in clinical samples. Clinically, these tests support the diagnosis, monitoring, or research of conditions linked to p63 expression, such as certain cancers or developmental disorders, by identifying specific protein markers in tissue or fluid specimens.

These diagnostic tools are typically regulated as IVD reagents, often requiring compliance with standards for accuracy, safety, and performance in laboratory settings. They are commonly supplied as kits or reagents for use in immunohistochemistry (IHC) or other immunoassay techniques, with classification and availability varying by jurisdiction and intended use.